No CRS summary available for this bill.
This section increases annual funding for the Health Care Fraud and Abuse Control Program to $490 million for HHS and Justice in FY2027, $520 million in FY2028, and $570 million in FY2029 (with CPI adjustments thereafter); to $320 million, $340 million, and $370 million for the HHS OIG over the same years (with CPI adjustments); to $230 million, $250 million, and $270 million for the FBI; to $1.28 billion, $1.38 billion, and $1.48 billion for the Medicare Integrity Program; and to $110 million, $120 million, and $130 million for the Medicare-Medicaid data match program. It expands OIG investigative authority to programs under Title I of the Affordable Care Act, clarifies that health plans include public and private plans, affirms authority to detect fraud and communicate with the public, and shifts the annual report deadline to Congress to April 1.
This section directs the Comptroller General to study the performance and effectiveness of the Health Care Fraud and Abuse Control Program. The study must analyze how the Departments of Health and Human Services and Justice have used appropriations and metrics to meet program goals under section 1128C of the Social Security Act, assess changes in outputs since the most recent GAO report, evaluate evidence of reduced fraud and abuse, and examine the timeliness of annual reports under section 1817(k)(5) of the Social Security Act. The Comptroller General must report findings and recommendations to Congress within 16 months of enactment.